<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>نوشته های Harvard University</title>
        <link>https://virgool.io/feed/@m_77474899</link>
        <description></description>
        <language>fa</language>
        <pubDate>2026-06-08 01:00:30</pubDate>
        <image>
            <url>https://files.virgool.io/upload/users/2031841/avatar/2T2kD1.png?height=120&amp;width=120</url>
            <title>Harvard University</title>
            <link>https://virgool.io/@m_77474899</link>
        </image>

                    <item>
                <title>Miss Hadis Erfani Namin</title>
                <link>https://virgool.io/@m_77474899/miss-hadis-erfani-namin-dhb5lgq7ohb0</link>
                <description>The compliance of the presented project with various phase II clinical trials in the preparation of the formulation is as follows:Don&#x27;t be discouraged, Mrs. Hadis Erfani Namin successfully passed the second clinical test of the project.Given the success of this stage, we will continue the construction process and start from stage 109.</description>
                <category>Harvard University</category>
                <author>Harvard University</author>
                <pubDate>Thu, 24 Apr 2025 22:24:21 +0330</pubDate>
            </item>
                    <item>
                <title>Miss Hadis Erfani Namin</title>
                <link>https://virgool.io/@m_77474899/miss-hadis-erfani-namin-hql1dqlynwq0</link>
                <description>Considering the cooperation of Harvard University and the University of Tsukuba and the preparation of the immortal life formulation and the relative increase of 250 years and Harvard&#x27;s performance in this project, the excellent research team is informed about the project and you, as the youngest Harvard researcher and the history of the extraordinary multiple sclerosis formulation, are invited to cooperate. We will keep you informed about the formulation in subsequent emails and your official cooperation will begin on April 11, 2025.Take action to open a foreign exchange account based on this cooperation ,And please note that you must open an account with your name and national ID number.</description>
                <category>Harvard University</category>
                <author>Harvard University</author>
                <pubDate>Tue, 11 Mar 2025 02:50:09 +0330</pubDate>
            </item>
                    <item>
                <title>Miss Hadis Erfani Namin</title>
                <link>https://virgool.io/@m_77474899/miss-hadis-erfani-namin-lnvmvzhtqj5k</link>
                <description>We want aploding the picture about Construction stagesIt is as follows:According to the images of the manufacturing and clinical testing stages, up to this stage, we had no impairment of vital signs, including breathing and heart rate, and with the feature of our refractive injections, we also prevented an increase in blood pressure, and this stage of the formulation was truly an amazing idea.</description>
                <category>Harvard University</category>
                <author>Harvard University</author>
                <pubDate>Sat, 08 Mar 2025 23:46:37 +0330</pubDate>
            </item>
                    <item>
                <title>Miss Hadis Erfani Namin</title>
                <link>https://virgool.io/@m_77474899/miss-hadis-erfani-namin-sxfo7gxtfksz</link>
                <description>Regarding the formulation preparation process, we will provide you with additional images and information. Please cooperate with us in the continuation of the process by confirming our steps.It is as follows:As can be seen in Table 2, the number of perceived stress scores in the experimental group in the pre-test stage was 35.93 and 22.6 in the post-test stage. In the control group, the scores in the pre-test and post-test stages were 29 and 26.27, respectively. In general, the descriptive findings show how much the scores in all several studies in the post-test stage in the group decreased compared to the control group.The use of policy tests requires several initial assumptions that in the case of inequality and less than 40 people, the size of the groups can be used according to the assumptions and they can be used from these tests (27). Accordingly, and considering that the test of the hypotheses of this study required univariate and multivariate analysis of covariance and analysis of variance with repeated measures, of course, they must be assumptions. The results of examining these assumptions are presented below.  The results obtained from the Kolmogorov-Smirnov test for the different samples of this study showed that the null hypothesis of normality of scores in all selected tests except for night shift systolic pressure in the experimental group remained, meaning that the samples used were normal and matched to the population, and the skewness and extraction of results were random. This assumption is in the same program as the one used in the study. In order to examine the equality of the assumption of equality of covariances or the relationships between research variables, the Box test was used. The results of the Box test were for systolic blood pressure (p=0.037, f=1.929, M=857.22) and diastolic blood pressure (p=0.032, f=1.975, M=402.23). This means that there is a significant difference between the subjects in the experimental and control groups.  The results of Levine&#x27;s test for perceived stress (p=0.063, F=743.3), morning systolic blood pressure (p=0.583, F=0.308), night systolic blood pressure (p=0.583, F=0.308), morning diastolic blood pressure (p=0.743, F=0.06, F=117.07) seem to indicate that Levine&#x27;s assumption of equality of variances in groups at the pre-test stage has not been accepted in society and remains, but this assumption is possible.The results of the analysis of covariance of the effect of hypnosis on stress reduction in patients with primary hypertension are presented in Table 3.As can be seen in Table 3, the pre-test and post-test of perceived stress are significantly related.  By controlling for this relationship, the difference between the adjusted means in the post-test phase (after controlling for pre-test scores) in the experimental and control groups is significant (p=0.001), the first hypothesis of the study is tested. In other words, hypnosis is the primary stressor in patients with hypertension in the post-test phase. The effect of hypnosis on stress reduction in the post-test phase was 0.625. This means that about 5.5% of the variance in perceived stress is related to group membership or the effect of hypnosis. The statistical power of 100% shows that the statistical accuracy of this test is excellent. In addition, the sample size was sufficient to test this hypothesis.Research findings in Table 4, the difference between the mean systolic blood pressure scores in the morning and evening in the pre-test and post-test phases is significant (p=0.001).The results show that nearly 14.1% of the individual differences are related to the difference between the two groups. In addition, the steps between blood pressure measurement and group membership are also significant (p=0.001). In other words, the difference between the diastolic blood pressure scores in the morning and evening in the two experimental and control groups is significant. The magnitude of these differences is about 0.537. That is, 53.7% of the variance or individual differences are related to the differences between the four steps of blood pressure measurement and group membership. In other words, hypnosis reduces the diastolic blood pressure of patients to the initial blood pressure. According to the results obtained in the table above, the difference between the four steps of diastolic blood pressure measurement is significant.  The results of pairwise comparisons using these four stages with the LSD test in the four stages of blood pressure measurement showed that the difference between the two systolic pressures in the morning and evening in the pre-test (p=0.001), the morning pre-test and the morning post-test (p=0.001), and the morning pre-test and the evening post-test are significant (p=0.001). Also, the difference between the two systolic pressures in the evening pre-test and the morning post-test (p=0.001) and the evening post-test (p=0.001) is significant. However, the difference in systolic pressure in the two stages of the morning post-test and the evening post-test is not significant. In general, the difference in systolic pressure in the pre-test and post-test stages is different in both morning and night, and according to the table, the blood pressure in the post-test stage is higher than in the pre-test stage.  Also, the results of pairwise comparisons of differences in the four stages of blood pressure measurement in the table above show that only the difference in diastolic pressure between the morning pre-test and the evening post-test (p=0.036) and the evening pre-test and the evening post-test (p=0.04) are significant. While the difference in diastolic blood pressure scores in other measurements throughout the study is not significant.</description>
                <category>Harvard University</category>
                <author>Harvard University</author>
                <pubDate>Sat, 08 Mar 2025 23:38:42 +0330</pubDate>
            </item>
                    <item>
                <title>Miss Hadis Erfani Namin</title>
                <link>https://virgool.io/@m_77474899/miss-hadis-erfani-namin-pc4jcenyakxm</link>
                <description> while appreciating your unceasing efforts, you are invited to attend the international seminar in New York as a presenter of multiple sclerosis formulation.Your unique formulation has undergone extensive testing and is FDA approvedAlso, your official invitation from the board of directors is as described in the picture below:Original invitation Your presence in seminar makes us proud</description>
                <category>Harvard University</category>
                <author>Harvard University</author>
                <pubDate>Thu, 03 Oct 2024 09:07:48 +0330</pubDate>
            </item>
                    <item>
                <title>حدیث عرفانی</title>
                <link>https://virgool.io/@m_77474899/%D8%AD%D8%AF%DB%8C%D8%AB-%D8%B9%D8%B1%D9%81%D8%A7%D9%86%DB%8C-p2glig8zqkhd</link>
                <description>حدیث عرفانی در حال حاضر درحال تحصیل در یکی از دبیرستان های استان تهران است این دانش اموز در سال ۱۳۸۶ متولد شد و در پایه ششم موفق شد ورودی دبیرستان استعداد های درخشان را بگیرد در پایه نهم در دبیرستان الزهرا واقع در استان تهران موفق به ارائه طرحی در ارتباط با فیثاغورس شد  این دانش اموز موفق با استعداد درخشانش اسمش در اسامی نخبه گان استان تهران ثبت شد او به تازگی طرحی راجب الکتریسیته ساکن ارائه داده است که طرح او به عنوان بهترین طرح های علم فیزیک شناخته شده است حدیث در سابقه ی تحصیلی خود موفق شده راه حل های کاربردی و حرفه ای تر ارائه دهد اساتید حدیث بر این باور هستند که او در آینده ی نه چندان دور تحول عظیمی در شاخه های علوم تجربی ایجاد می‌کند‌حدیث در شاخه های علوم تجربی بسیار فعال بوده و برای دومین بار طرحی را در شاخه های ریاضیات و فیزیک ارائه داده استفعالیت های حدیث توجه اکثر فیزیکدان ها و ریاضیدان ها را جلب کرده .از او به عنوان اصلاح کننده ی روابط اصلی علوم تجربی یاد میکنند حدیث عرفانی فقط در شاخه های فیزیک و ریاضی فعالیت ندارد بلکه در شاخه ی زیست شناسی هم بسیار فعال بوده و چهار مقاله منتشر کرده که مهم ترین مقاله ی او راجب سلول های بنیادی و شناسی عصب ها در بیماری تصلب پراکنده(ام اس) است در مصاحبه ی با اساتید حدیث عرفانی ،اساتید به اطلاع رسانند که حدیث طرح های بسیار جالب و علمی را ارائه می‌دهد که در تاریخ علوم تجربی اسم او ماندگار خواهد شد  حدیث  برای پروپوزال آخرین واحد ژنتیکش مقاله بی نظیر ارائه کرد که نظر اکثر مصحح هارا جلب کرد و استاد حدیث بر این باور بود که مقاله ی پایان‌نامه حدیث جزء برترین ها خواهد بود و در مصاحبه اعلام کرده بود دور از انتظار نیست که طرح حدیث برتر و اول شود که همان گونه که به اطلاع رسید مقاله ی حدیث در پژوهشگران اول و برتر شد و بار دیگر نظر اغلب اساتید را جلب کردحدیث توانست با ارسال یک فرمولاسیون منحصر به فرد به هیئت مدیره دانشگاه هاروارد در سمینار بین‌المللی راه پیدا کند و به عنوان ارائه کننده فرمولاسیون در این سمینار حضور پیدا کند همچنین با توجه به اطلاعات بدست آمده این فرمولاسیون دارای تاییده FDA است </description>
                <category>Harvard University</category>
                <author>Harvard University</author>
                <pubDate>Fri, 03 Feb 2023 14:32:41 +0330</pubDate>
            </item>
            </channel>
</rss>